The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watford, W. T.
Right arrow Articles by Frank, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watford, W. T.
Right arrow Articles by Frank, M. M.
The Journal of Immunology, 2001, 167: 6593-6600.
Copyright © 2001 by The American Association of Immunologists

Surfactant Protein A Regulates Complement Activation1

Wendy T. Watford*, Jo Rae Wright2,*, C. Garren Hester{dagger}, Haixiang Jiang{dagger} and Michael M. Frank{dagger}

Departments of * Cell Biology and {dagger} Pediatrics, Duke University Medical Center, Durham, NC 27710

Complement proteins aid in the recognition and clearance of pathogens from the body. C1, the first protein of the classical pathway of complement activation, is a calcium-dependent complex of one molecule of C1q and two molecules each of C1r and C1s, the serine proteases that cleave complement proteins. Upon binding of C1q to Ag-bound IgG or IgM, C1r and C1s are sequentially activated and initiate the classical pathway of complement. Because of structural and functional similarities between C1q and members of the collectin family of proteins, including pulmonary surfactant protein A (SP-A), we hypothesized that SP-A may interact with and regulate proteins of the complement system. Previously, SP-A was shown to bind to C1q, but the functional significance of this interaction has not been investigated. Binding studies confirmed that SP-A binds directly to C1q, but only weakly to intact C1. Further investigation revealed that the binding of SP-A to C1q prevents the association of C1q with C1r and C1s, and therefore the formation of the active C1 complex required for classical pathway activation. This finding suggests that SP-A may share a common binding site for C1r and C1s or Clq. SP-A also prevented C1q and C1 from binding to immune complexes. Furthermore, SP-A blocked the ability of C1q to restore classical pathway activity to C1q-depleted serum. SP-A may down-regulate complement activity through its association with C1q. We hypothesize that SP-A may serve a protective role in the lung by preventing C1q-mediated complement activation and inflammation along the delicate alveolar epithelium.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Gil, F. X. McCormack, and A. M. LeVine
Surfactant Protein A Modulates Cell Surface Expression of CR3 on Alveolar Macrophages and Enhances CR3-mediated Phagocytosis
J. Biol. Chem., March 20, 2009; 284(12): 7495 - 7504.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Rittirsch, M. A. Flierl, D. E. Day, B. A. Nadeau, S. R. McGuire, L. M. Hoesel, K. Ipaktchi, F. S. Zetoune, J. V. Sarma, L. Leng, et al.
Acute Lung Injury Induced by Lipopolysaccharide Is Independent of Complement Activation
J. Immunol., June 1, 2008; 180(11): 7664 - 7672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. S. Bolger, D. S. Ross, H. Jiang, M. M. Frank, A. J. Ghio, D. A. Schwartz, and J. R. Wright
Complement levels and activity in the normal and LPS-injured lung
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L748 - L759.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. M. Lin and J. R. Wright
Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes.
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1199 - L1206.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Liu, Y. Endo, D. Iwaki, M. Nakata, M. Matsushita, I. Wada, K. Inoue, M. Munakata, and T. Fujita
Human M-Ficolin Is a Secretory Protein That Activates the Lectin Complement Pathway
J. Immunol., September 1, 2005; 175(5): 3150 - 3156.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. S. Ferguson, J. J. Weis, J. L. Martin, and L. S. Schlesinger
Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid
Infect. Immun., May 1, 2004; 72(5): 2564 - 2573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. G. Brinker, H. Garner, and J. R. Wright
Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells
Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L232 - L241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Yang, C. Milla, A. Panoskaltsis-Mortari, S. Hawgood, B. R. Blazar, and I. Y. Haddad
Surfactant Protein A Decreases Lung Injury and Mortality after Murine Marrow Transplantation
Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 297 - 305.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. S. Butler, D. Sim, E. Tam, D. Devine, and C. M. Overall
Mannose-binding Lectin (MBL) Mutants Are Susceptible to Matrix Metalloproteinase Proteolysis. POTENTIAL ROLE IN HUMAN MBL DEFICIENCY
J. Biol. Chem., May 10, 2002; 277(20): 17511 - 17519.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.